Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
CAPLACIZUMAB
Cablivi
Acquired Thrombotic Thrombocytopenic Purpura
ALX-0681-2.1/10TITANNCT01151423Summary
CAPLACIZUMAB
Cablivi
Healthy Volunteers
ALX0681-C102NANCT02189733Summary
CAPLACIZUMAB
Cablivi
Healthy Volunteers
ALX0681-C103NANCT03172208Summary
CAPLACIZUMAB
Cablivi
Acquired Thrombotic Thrombocytopenic Purpura
ALX0681-C301HERCULESNCT02553317Summary
CAPLACIZUMAB
Cablivi
Acquired Thrombotic Thrombocytopenic Purpura
EFC16297NANCT04074187Publication's reference
CAPLACIZUMAB
CABLIVI®
Acquired Thrombotic Thrombocytopenic Purpura
LTS16371Post-HERCULESNCT02878603Tabulated Results
CELIVARONE
Not marketed
Arrhythmia Prophylaxis
DRI10936ALPHEENCT00993382Publication's reference
CELIVARONE
Not marketed
Atrial Fibrillation
DRI5165MAIANCT00233441Publication's reference
CELIVARONE
Not marketed
Arrhythmia
DRI5349ICARIOSNCT00232297Publication's reference
CELIVARONE
Not marketed
Atrial Fibrillation
DRI5760CORYFEENCT00232310Publication's reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted